Mr. Jirawat Akranuponpong Chief Financial Officer of Applied DB Public Company Limited (ADB) revealed that the company has targeted revenue for the year 64 to grow 10-15% from the previous year, making 1,376.90 million baht, with the 2Q21 revenue already at 843.43. million baht as a result of the plastics compound business that has grown greatly especially Medical Graded PVC, Wire and Cable PVC, and General Graded PVC including grout products which rely on the construction business.
The company admits that in the second half of the year, it is likely to be affected by COVID-19, but its portfolio has been spread across a number of categories. This reduces the risk of factors that will affect it. Including likely to grow from exports to replace From the export market is still growing well.
For the direction of operations in the second half of this year The company will achieve the goals that have been set. because it would avoid the impact of COVID-19 both directly and indirectly But the company will adjust to the situation. Manage production without interruption or stop in order to deliver products to customers.
“In the second half of this year The plastics compound business is still the main supporting factor. Even though we have been affected by Covid-19 and there are still some silicone sealants that have already received orders. It has the opportunity to export more. In the glue and sealant segment, there is also a high profit margin.”
Mr. Jirawat said
On the factor of the baht that has depreciated quite a lot at the moment. The company looks to have a positive impact. because it is received in dollars while imports of raw materials from abroad will be in a similar proportion. resulting in limited impact.
Mr. Jirawat said that the Board of Directors has approved the establishment of a subsidiary ADB BIO Co.,Ltd to operate bioplastic business. The goal is to focus on various biotech-related businesses. related to the products that ADB has expertise in after having started research and development on the subject for a while.
In addition, the company is in the process of negotiating with partners to jointly invest in the skincare business in the process of studying various productions. Both skill care products and investment style However, there may be some delays or delays. due to the covid-19 situation.